Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

P32/98 hemifumarate

SKU: orb1704908

Description

P32/98 hemifumarate is a potent and selective DPP4 inhibitor used in diabetes research. It demonstrates anti-hyperglycemic effects by enhancing insulin sensitivity and β-cell function in vivo, as shown in Zucker diabetic fatty (ZDF) rat studies. Its application extends to investigating inflammatory conditions like colitis.

Research Area

Protein Biochemistry

Images & Validation

Key Properties

CAS Number251572-86-8
MW520.71
Purity99.07% (May vary between batches)
FormulaC22H40N4O6S2
SMILESOC(/C=C/C(O)=O)=O.CC[C@H](C)[C@H](N)C(N1CCSC1)=O.CC[C@H](C)[C@H](N)C(N2CCSC2)=O
TargetDPP-4

Bioactivity

Target IC50
DPP4:130 nM (Ki)
In Vivo
In Zucker diabetic fatty rats, P32/98 (hemifumarate) (25 mg/kg; oral gavage; once daily) significantly improved glucose tolerance.
In Vitro
In porcine proximal tubular cells,P32/98 (hemifumarate) (10 μM; 96 hours) showed no cytotoxicity.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

DPP4, DPP-4, P32/98 (hemifumarate), P32/98 (hemifumarate)(136259-20-6 free base), P32/98
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 140.00
5 mg
$ 270.00
10 mg
$ 390.00
25 mg
$ 610.00
50 mg
$ 860.00
100 mg
$ 1,130.00
500 mg
$ 2,220.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry